Appeal No. 1999-0710
Application No. 08/716,875
Antibodies, Inc., 802 F.2d 1367, 1385, 231 USPQ 81, 94-95
(Fed. Cir. 1986), cert. denied, 480 U.S. 947 (1987);
Shatterproof Glass Corp. v. Libbey-Owens Ford Co., 758 F.2d
613, 624, 225 USPQ 634, 641 (Fed. Cir. 1985). In the present
case, we think the detailed explanation in appellants’
specification on pages 6-8 of how the “mean free path” and
“bovine blood absorbency rate” of a layer of material are
determined are such that those skilled in the art would be
reasonably apprised of the metes and bounds of the claims.
Accordingly, the examiner’s rejection under 35 U.S.C. § 112,
second paragraph, will not be sustained.
The 35 U.S.C. § 102(b) rejection
Anticipation is established only when a single prior art
reference discloses, expressly or under principles of
inherency, each and every element of a claimed invention. RCA
Corp. v. Applied Digital Data Sys., Inc., 730 F.2d 1440, 1444,
221 USPQ 385, 388 (Fed. Cir. 1984).
Each of the independent claims on appeal recites that the
transfer layer comprises structural elements defining a mean
free path within the range of 50 microns to about 200 microns,
5
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007